Effect of (E)-2-(4-bromophenyl)-1-(3,4-dihydroxyphenyl) Ethanone Oxime on Proliferation and Activation of Mice Lymphocytes
Abstract
To study the effects of (E)-2-(4-bromophenyl)-1-(3,4-dihydroxyphenyl) ethanone oxime (BDEO) on the proliferation and activation of the mice's splenic lymphocytes and the peripheral blood lymphocytes induced by Concanavalin A (Con A) in vitro and in vivo, and its molecular mechanism. Methods During the lymphocyte proliferation and activation induced by Con A in vitro, MTT and cell counting were used to detect the transformation rates and survival rates of lymphocytes, and ELISA was used to measure the activity of caspase-9; moreover, the levels of Bax, Bcl-2 and caspase-3 were determined by Western blot, in order to observe the effects of BDEO on cell proliferation and activation. The effects of administration of Con A 〔15 mg/(kg·d)〕 and BDEO 〔(3, 6 mg/(kg·d)〕 by intraperitoneal injection on transformation rates of spleen cells and peripheral blood lymphocyte, as well as phagocytosis rate of peritoneal macrophages in mice were also observed in vivo. Results 0.3-1 μmol/L BDEO significantly inhibited the transformation rates and growth of mice lymphocyte (P<0.05). The activity of caspase-9 and the levels of mitochondrial pro-apoptotic protein Bax and Bak gradually increased, then decreased as the BDEO continually accumulated. Anti-apoptotic protein Bcl-2 as well as mitochondrial Cyt C levels first decreased then increased gradually, and cytoplasmic Cyt C, cleaved caspase-9 and cleaved caspase-3 levels showed firstly a increase, then decrease gradually. Additionally, administration of BDEO by intraperitoneal injection significantly inhibited proliferation of spleen lymphocytes and peripheral blood lymphocyte, as well as phagocytosis of peritoneal macrophagesin in mice. Conclusion BDEO might regulate the proliferation and activation of lymphocytes through activation of caspase-3 mainly via a mitochondrial intrinsic pathway; the inhibiting [CM(155mm]effect on the proliferation and transformation rate of lymphocytes was significant when the concentration of BDEO was relatively low; as the concentration accumulated increasingly, the inhibiting effect reduced. The results indicated that BDEO has immunosuppressive activity.
Keywords: Lymphocytes, BDEO, Proliferation, Activation, Cyt C, Caspase-9
Full Text:
PDFReferences
Yang JW. Han ST, Kim YS, et al. Effects of a cGMP-specific phosphodiesterase inhibitor on expression of endothelial nitric oxide synthase and vascular endothelial growth factor in rats with cyclosporine-induced nephrotoxicity. Transplant Proc, 2010;42(10):4625-4632.
Bossini N, Sandrini S, Casari S, et al. Kidney transplantation in HIV-positive patients treated with a steroid-free immunosuppressive regimen. Transpl Int,2014 Jun 25. doi: 10. 1111/tri. 12377. CEpub ahead of print]]
Matz M, Weber U, Mashreghi M. Effects of the new immunosuppressive agent AEB071 on human immune cells. Nephrol Dial Transplant,2010;25(7):226-230.
Li HQ, Luo Y. Song R, et al. Design, synthesis, and immunosuppressive activity of new deoxybenzoin derivatives. Chem Med Chem.2010;5(7); 1117-1122.
Yano H. Thakur A, Tomaszewski EN. Ipilimumab augments antitumor activity of bispecific antibody-armed T cells. J Transl Med.2014 ; 12( 1); 191-192.
Ward MD, Jones DE. Goldman МD. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis. Expert Opin Drug Saf .2014; 13(7); 989-998.
Aoudjehane L, Podevin P. Conti F. Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J . 2007; 21 (7): 1433-1444.
Ntranos A, HallO, Robinson DP. FTY720 impairs СD8 T-cell function independently of the sphingosine-1-phosphate pathway. J Neuroimmunol,2014 ; 270(1-2); 13-21.
Kockx M, Guo DL. Traini M. Cyclosporin A decreases apolipoprotein P' secretion from human macrophages via a protein phosphatase 2B-dependent and ATP-binding cassette transporter A1 ( ABCA1 )-independent pathway.J Biol Chem, 2009;284(36):24144-24154.
Hong JC, Kahan D. Immunosuppressive agents in organ transplantation; past, present and future. Semin Nephrol, 2000;(2):108-125.
Opelz G, Dohler В, Opelz G. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation. Transplantation, 2009;87(6):795-802.
Refbacks
- There are currently no refbacks.



